🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

City of Hope

5 posts
Read More

Thalia Therapeutics (AIM: THAT) completes Sanmirna acquisition to add Phase 1 AML asset

Thalia Therapeutics has completed its acquisition of Sanmirna Therapeutics, adding the Phase 1 miRisten programme for relapsed or refractory acute myeloid leukaemia. The deal accelerates Thalia’s transition into clinical-stage RNA therapeutics, but more than doubles its share count and leaves future value dependent on safety data, early biological evidence and further financing.